Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy

Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy

Abstract Background Patients with breast cancer who have a pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) have improved survival. We hypothesize that once pCR has been achieved, there is no difference in subsequent postsurgical recurrence-free survival (RFS), whichever NACT re...

Full description

Bibliographic Details
Main Authors: Anna Weiss, Sami I. Bashour, Kenneth Hess, Alastair M. Thompson, Nuhad K. Ibrahim
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Breast Cancer Research
Subjects:
Neoadjuvant chemotherapy
Pathologic complete response
De-escalation of chemotherapy
Breast cancer
Survival after pCR
Online Access:http://link.springer.com/article/10.1186/s13058-018-0945-7

Internet

http://link.springer.com/article/10.1186/s13058-018-0945-7

Similar Items